Budesonide-formoterol 160-4.5 10.2GM
Ended Awarded
- Contract number
- SPE2DB26FUWVD
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $3,791
Award facts
- Contract value 100% obligated
- $3,790.80 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $3,790.80 to AmerisourceBergen Drug Corp for Budesonide-Formoterol 160-4.5 10.2GM pharmaceutical supply. This competitively awarded, firm fixed price delivery order was issued on November 6, 2025, with an ultimate completion date of November 7, 2025, and will be performed at the contractor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract vehicle with DLA Troop Support Medical (SPE2DX), a $999.999 billion prime contract running through December 2026 that serves as a comprehensive pharmaceutical support mechanism for military healthcare systems worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, is a critical federal medical procurement vendor specializing in brand-name and generic medications, vaccines, medical devices, and specialized healthcare commodities across multiple therapeutic domains. The company's extensive portfolio of federal contract awards with the Defense Logistics Agency and its Medical Supply Chain demonstrates its capability to fulfill diverse pharmaceutical needs for military and veteran healthcare systems. This delivery order for the corticosteroid-bronchodilator combination inhaler medication reflects the company's continued role in supporting the Defense Health Agency and other federal healthcare customers through the flexible and comprehensive DLA Troop Support Medical contract vehicle.
Quick answers
Who was awarded contract SPE2DB26FUWVD?
SPE2DB26FUWVD was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DB26FUWVD worth?
The government has obligated $3,791 on SPE2DB26FUWVD.
Is contract SPE2DB26FUWVD an order under another contract?
Yes. SPE2DB26FUWVD is a delivery order under SPE2DB25D3018, an indefinite delivery contract.
Was contract SPE2DB26FUWVD competed?
The extent of competition for SPE2DB26FUWVD was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award